INTRODUCTION
The human VPAC 1 receptor is expressed in liver, breast, kidney, prostate, bladder, pancreatic ducts, thyroid gland, lymphoid tissues and gastrointestinal mucosa and in most of the tumors derived from these tissues. The VPAC 1 receptor is a member of family B of G protein coupled receptors (GPCR), which have seven transmembrane helices (7 TM). This family includes the VPAC 2 -, secretin-, PAC 1 -, glucagon-, glucagon like-peptide 1 and 2-, calcitonin-, corticotropin-releasing factor-and parathyroid hormone (PTH) receptors. The physiological ligands of the VPAC 1 receptor are Vasoactive Intestinal Polypeptide (VIP) and Pituitary Adenylate Cyclase Activating Peptide (PACAP) (Dickson and Finlayson, 2009 ).
Extensive studies of the largest family of GPCRs, the GPCR-A/rhodopsin family led to the identification of key steps frequently involved in the early signaling events of this family.
These include the disruption of an ionic interaction between the cytoplasmic face of TM3 and TM6 maintaining the receptor preferentially in a ground inactive conformation in absence of agonist (ionic lock) and a "rotamer toggle switch" (modulation of the helix conformation around a proline-kink) in TM6 causing key sequences to be exposed to cytoplasmic binding partners (Ballesteros et al., 2001; Schwartz et al., 2006) .
The mechanisms regulating the GPCR-B family signal transduction are less precisely understood, since no X-ray structure of the whole receptor is available, and conserved motifs of the GPCR-A family (E/DRY at TM3, NPXXY at TM7) are absent in the GPCR-B family.
Although recent studies have solved the structure of the N terminus of several family B receptors (CRF, PTH, PAC 1 , GIP, GLP-1) and clarified their role in ligand binding (Grace et al., 2007; Parthier et al., 2007; Pioszak and Xu, 2008; Runge et al., 2008; Sun et al., 2007) , there is little information on the events that follow ligand binding. Considering the VPAC 1 receptor as a paradigm for class B, it actually appears that a large network of interactions must be considered. Indeed, on the basis of mutagenesis studies, it has been proposed that TM1, M O L # 6 3 5 7 8 5 TM2, TM3, and TM6, but also the intracellular loop 3 (ICL3) and the proximal part of the Cterminal intracytoplasmic tail take part in the receptor signal transduction (Gaudin et al., 1998; Gaudin et al., 1999; Couvineau et al., 2003; Langer and Robberecht, 2007) .
In the present study, a network of interactions that stabilize the VPAC 1 receptor conformation in absence of ligand is identified by combining modeling and mutagenesis studies, and is proposed to be involved in receptor activation. This network includes an arginine (R   188   ) located in TM2, previously demonstrated by complementary-paired mutagenesis to interact with the D 3 residue of VIP (Solano et al., 2001) , an asparagine (N 229 ) located in TM3, important for VPAC 1 and VPAC 2 mediated G protein activation (Nachtergael et al., 2006) and a glutamine (Q 380 ) conserved among the GPCR-B family members and located in TM7.
To our knowledge, this is the first identification of early steps that lead to the receptor activation of a GPCR-B family member upon ligand binding.
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MATERIALS AND METHODS

Comparative modeling procedure
Comparative modeling was carried out by Modeller 9V3 (Marti-Renom et al., 2000) , on the basis of alignments between the target and template sequences obtained as described in
Results. The modeling was constrained, in order to create an obligate disulfide bond between the residues Cys 215 at the extracellular end of TM3 and Cys 285 in the extracellular loop 2 (ECL2); this disulfide bridge is indeed known to occur in GPCR-B members. All models were stepwise energy-relaxed: 1) with all heavy-atoms fixed; 2) with backbone atoms fixed and
3) with C α atoms fixed. Gromacs 3.3.1 was used for energy calculations (Lindahl et al., 2001) .
Quality assessment of the structural models
To evaluate the quality of the structural models generated from different sequence alignments, we used the membrane score approach (Chugunov et al., 2007b; Chugunov et al., 2007a) , which was developed for the assessment of the packing quality of α -helical TM domains of membrane proteins (MP). In this method, a database-derived scoring function (S mem ) is used to quantitatively estimate the fitness of a given amino acid residue for its three-dimensional class of protein-membrane environment. This scoring function was derived from the analysis of a non-redundant set of α -helical MP structures (Chugunov et al., 2007a) . The larger S mem the model has, the better it is packed in space. Generally, models with S mem <0 should be considered as misfolded. This method has been proven to be useful in discriminating close-tonative structures from large decoy sets built from misleading alignments (Chugunov et al., 2007b) . A second quality assessment, performed on the best structural models identified by the membrane score approach, consisted of a detailed analysis of the variability moment vectors. In a first step, all protein sequences homologous to the target are aligned, and the amino acid variability at each position is computed. In a second step, a vector is assigned to each residue in each TM helix of the 3D model of the target. The vector is put in a plane
parallel to the surface of the membrane, points out of the helix, and its amplitude is proportional to the variability of the residue among the members of the target family. The resulting vector is computed for each helix, and shows thus the most variable side of the helix, which should be exposed to the membrane, since evolution is known to better conserve amino acids that point towards the protein core and are likely to be involved in important
interactions. The models that fulfill the previous quality assessments were submitted to a 1 ns molecular dynamics (MD) simulation in vacuum at 500 K, with fixed C α atoms solely for exploration of side chains motility (not for model optimization). GROMACS 3.3.1 (Lindahl et al., 2001 ) was used for that purpose. More sophisticated MD calculations would require an explicitly defined medium (membrane) and advanced setup, but for our purposes, the sampling of the side chain conformations with a fixed backbone is sufficient. During each MD simulation, 1000 frames were memorized, and the S mem values were computed for each of them to cumulate score distributions.
Construction and expression of VPAC 1 mutant receptors
The cell lines expressing wild-type (wt) VPAC 1 , as well as R 188 A, R 188 Q, N
229
A and N 229 Q mutant receptors, have been detailed in previous publications (Nachtergael et al., 2006; Solano et al., 2001) . The generation of the other mutated receptors was achieved using the QuikChange Site-Directed Mutagenesis kit (Stratagene, LaJolla CA, USA), according to the manufacturer's instructions. Confirmation of the expected mutation was achieved by DNA sequencing on an ABI automated sequencing apparatus, using the BigDye Terminator Sequencing Prism Kit from ABI (Perkin-Elmer, CA, USA). Following DNA amplification using a midiprep endotoxin-free kit (Promega, CA, USA), the complete nucleotide sequence of the receptor coding region was verified by DNA sequencing. 20 µg of DNA was transfected by electroporation in CHO cell line expressing aequorin (kindly provided by Vincent Dupriez, Euroscreen SA, Belgium) as described in (Nachtergael et al., 2006) . 
Membrane preparation
Membranes were prepared from scraped cells lysed in 1 mM NaHCO 3 followed by immediate freezing in liquid nitrogen. After thawing, the lysate was first centrifuged at 4°C
for 10 min at 400 g and the supernatant was further centrifuged at 20 000 g for 10 min. The resulting pellet, resuspended in 1 mM NaHCO 3 was used immediately as a crude membrane fraction.
Adenylate cyclase activation assay
Adenylate cyclase activity was determined by the procedure described (Salomon et al., 1974) .
Membrane proteins (3-15 µg) were incubated in a total volume of 60 µl containing 0.5 mM Binding studies on VPAC 1 wt and mutant receptors were performed by using the [ 125 I]-VIP.
The non specific binding was defined as residual binding in the presence of 1 µM unlabeled VIP. Binding was performed for 30 min at 23°C in a total volume of 120 µl containing 20 mM Tris-maleate, 2 mM MgCl 2 , 0.1 mg/ml bacitracin, 1% bovine serum albumin (pH 7.4) buffer using 3 to 30 µg of protein per assay. Bound and free radioactivity were separated by filtration through glass-fiber GF/C filters presoaked for 24 h in 0.01% polyethyleneimine and rinsed three times with a 20 mM (pH 7.4) sodium phosphate buffer containing 0.8 % bovine serum albumin. The binding sites density was estimated by analysis of homologous competition curves assuming that the labelled and unlabeled ligands had the same affinity for the receptors.
Peptide synthesis
The peptides used were synthesized in our laboratory as described in (Nachtergael et al., 2006) . Peptide purity (at least 95%) was assessed by capillary electrophoresis, and conformity by electrospray MS.
Data analysis
All competition curves, dose-response curves, pIC 50 and pEC 50 values were calculated using non linear regression (GraphPad Prism software). Statistical analyses were performed with the same software.
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RESULTS
Molecular modeling
Since no experimental VPAC 1 structure is available, molecular modeling of its TM domain was performed in view of identifying residues involved in VIP binding and receptor activation, selecting potentially interesting mutations to be studied experimentally and rationalizing the results of these analyses. We took advantage of a preliminary 3D model of the TM domain of VPAC 1 (Conner et al., 2005) and designed a new, carefully optimized,
model.
An important ingredient towards optimal modeling is the production of a correct amino acid alignment between the template and target proteins, given the almost non-significant level of sequence identity between the members of the GPCR-B family and the GPCR-A receptors for which several structures have been solved (Palczewski et al., 2000; Okada et al., 2004; Cherezov et al., 2007; Warne et al., 2008; Jaakola et al., 2008) . There is moreover no evidence that the receptors' activation mechanism should be the same in GPCR-A and GPCR-B, and involve similar intermediate states. So, there is no clear reason of selecting any particular structural template for modeling GPCR-B proteins. Here we chose the wellresolved crystallographic structure of bovine visual rhodopsin (PDB code: 1U19) (Okada et al., 2004) .
Sequence alignments and TM model
Since commonly available and automatic sequence alignment methods fail to produce reliable OPSD-VPAC 1 alignments due to their very low sequence identity, we turned to an iterative and partly manual procedure of sequence alignment selection.
In a first step, we compiled a set of four OPSD-VPAC 1 alignments (Aln-1 to Aln-4). Aln-1 was adapted from the approach of Frimurer & Bywater for the modeling of the GLP-1
receptor based on a comprehensive sequence analysis, a low-resolution structure of frog rhodopsin obtained by electron crystallography, and the so-called "cold-spot" alignment method for sequences with low similarity (Frimurer and Bywater, 1999) Aln-2 was taken from the work of Bisstantz et al. (Bissantz et al., 2004) , in which they defined a framework for the automated modeling of GPCRs of the three main subfamilies. The latter approach tends to superimpose highly conserved positions, irrespective of their physicochemical nature, rather than residues viewed as similar according to substitution matrices. Aln-3 was built manually, by implementing a kind of "cold-spot" approach idea. No gaps were allowed inside the TM domain; they were moved to the middle of loop regions. Aln-4 was produced by mGenThreader (McGuffin et al., 2000) via the BioInfoBank Meta Server (Ginalski et al., 2003) .All these alignments along with final variant can be found in Figure S1 .
The four alignments were in agreement for helices TM3, TM6 and TM7, but they differed considerably for the other ones: we obtained 4, 2, 2, and 3 variants for TM1, TM2, TM4 and TM5, respectively. Considering the sequence as a whole, this corresponds to 48 (4×2×2×3) global alignment variants of the TM region.
Each of the 48 alignments so obtained was used to generate a set of ten structural models, using the comparative modeling approach described in Methods. The packing quality of the TM helices in these 480 models was assessed using the membrane score S mem (see Methods).
In a second step, the alignment that produced the best structural models, which display the maximum S mem value averaged over the 10 models (< S mem >), was used as starting point for further exploration of the alignment space This involved generating 3 7 =2187 alignment variants by shifting each of the 7 TM helices independently by −1, 0, or +1 residue. From each of these new alignments, 10 structural models were built and evaluated on the basis of the membrane score S mem . The best alignment at this stage, referred to as ReAln (see Fig. S1 ), was submitted again to the same helix shifting procedure, leading to 2187 other alignment This article has not been copyedited and formatted. The final version may differ from this version.
variants. However, the models produced from these new alignments are not superior to that from ReAln (data not shown). The procedure was therefore stopped, and ReAln was considered to be the optimal alignment as measured by the S mem score.
Given the shortcomings of the empirical membrane score method, it is essential to consider available data on homologous proteins and check whether the model meets the general packing principles for membrane proteins such as hydrophobicity and variability organization.
In particular, it is well known that the side of a given secondary structure element (here, an α -helix) that has mutated most during evolution is always exposed to the surrounding medium (here, the membrane). On the contrary, the conserved side, which is likely to play some important structural or functional roles, is buried inside the protein interior (Beuming and Weinstein, 2004) . We performed thus a detailed analysis of the variability moment vectors in the structural model (see experimental procedures and Figure S2 ), and corrected manually the ReAln alignment to fulfill the requirement that the most variable side of the helix should face the membrane. The final alignment, which we refer to as finalAln, is given in Fig. 1 (see also Despite a better variability and hydrophobicity organization, the models based on the final alignment finalAln (Fig. 1) 
score in the case of finalAln than for ReAln. Note that the four initial alignments (Aln-1-4), which came from a single source and not from an iterative semi-manual alignment procedure (Fig. S1 ), exhibit much worse S mem distributions than ReAln and finalAln (Fig. 2) . We thus definitely consider finalAln as the optimal alignment and the resulting 3D models as the optimal model structures.
Analysis of the TM model
The resulting model of VPAC 1 TM domain, depicted in Fig. 3 , has native-like variability (Fig. S2 ) and hydrophobicity organization (data not shown). In addition, all residues that are known to be functionally important are located in an environment that provides a reasonable explanation of their function. The only polar stretch in contact with the membrane is located on the TM4 surface ( Figure S3 ), which has been experimentally shown to correspond to a dimerization site in the case of the secretin receptor (Harikumar et al., 2007) . This site may thus be expected to correspond to a dimerization site for the VPAC 1 receptor too.
As seen in Figure 3 , residues that are known to mediate ligand binding -R 188 , K 195 and D 196 in TM2 (Solano et al., 2001; Langer and Robberecht, 2007) -form a cavity close to the exterior surface of the membrane, with the charged group of R 188 at the very bottom of the cavity. An interhelical interaction R 188 -Q 380 between TM2 and TM7, analogous to the R 233 -Q 451 interaction shown to be important for PTHR1 receptor (Gardella et al., 1996) , is moreover observed in the model. This interaction can partially compensate for the unfavorable presence of the positive charge of R 188 inside the helix bundle in absence of ligand. These two residues belong to a chain of polar residues inside the receptor bundle: R 188 in TM2 -Q 380 in TM7 -N 229 in TM3 (Figure 3c ). H 178 in TM2 and T 343 in TM6, described as important for the activation and constitutive activity of some family B receptors (Hjorth et al., 1998; Gaudin et al., 1999) , are as well incorporated in a polar network in the cytoplasmic half of the TM domain of the receptor.
M
Experimental analyses Q 380 located in TM7 is important for VPAC 1 activation
Mutagenesis and functional studies previously identified an asparagine located in TM3 (N 229 and N 216 in VPAC 1 and VPAC 2 receptor respectively) that is essential for receptor activation (Nachtergael et al., 2006) . Indeed, as reported in To identify other residues likely to take part in the network, we took advantage of the 3D model presented here above and searched for amino acids located in vicinity of N 229 and R
188
.
As shown in Figure 3, A mutant was so much affected that we were unable to characterize it (Solano et al., 2001) . Cell surface expression of all mutants tested was evaluated by FACS analysis using specific monoclonal anti-VPAC 1 antibody to ensure that the effect observed is not due to receptor misfolding or altered cell surface targeting (data not shown).
As shown in Table 1 , the capability to stimulate adenylate cyclase activity of the N 229 A/Q 380 A mutant is lower than that of the wt and similar to that of the individual single-site mutants. of the high resolution structure of members of family A of GPCRs (Palczewski et al., 2000; Okada et al., 2004; Cherezov et al., 2007; Warne et al., 2008; Jaakola et al., 2008) confirmed that receptor activation is mediated by relative movements among the seven transmembrane helices that are stabilized by different network of interactions. However, as these key residues are not conserved in family B GPCRs, and structural data are only the TM domain of the receptor. This is illustrated by the fact that a Zn(II) bridge between helices 3 and 6 of the PTH receptor constrains the receptor in a conformation unable to promote PTH-mediated G-protein activation while agonist induced internalization or phosphorylation were preserved (Castro et al., 2005; Vilardaga et al., 2001 ).
In the present study, by combining pharmacological and in silico approaches, we have identified a network of interactions between residues located in helices 2, 3 and 7 of the VPAC 1 receptor, which are involved in the stabilization of the receptor in absence of agonist and in early steps of receptor activation. We propose that, in absence of VIP, the Q substitutions (Nachtergael et al., 2006) , and that the substitution of both residues to Ala had a less than additive effect. The altered activation observed with these mutants cannot be attributed to the disruption of the binding pocket because the affinities for VIP were not affected for N N mutants still bind the G protein but fail to activate it properly. As shown for several GPCRs, it is expected that reciprocal exchange of two residues involved in a direct interaction should restore the activity of the receptor. We found that the N 299 Q/Q 380 N substitution partially restored the receptor activity. The N 299 A/Q 380 A shows a similar anticooperativity since the loss in activity of the double mutant is only slightly larger than that of each single-site mutation. Note that both double mutants present a loss in binding affinity, which contributes to the loss in activity. As a consequence, the actual anti-cooperative effect is even stronger than suggested by the comparison of the measured and expected ΔpEC 50 values (Table 1b) . Thus altogether the results suggest that the interaction between N 229 and Q 380 is important for VPAC 1 mediated G protein activation.
The 3D model can be taken to suggest that Q 380 functions as a floating "ferry-boat", switching To our knowledge, this is the first study that identified, in a member of family B GPCRs, interactions between residues located in transmembrane helices that are involved in the stabilization of the receptor conformation. Interestingly, R 172 in the closely related VPAC 2 receptor and R 166 in the secretin receptor (these positions correspond to R 188 in VPAC 1 ) also interact with the D 3 side chain of VIP and secretin, respectively (Di Paolo et al., 1998; Langer and Robberecht, 2007) . Some of us also previously demonstrated that N 216 in VPAC 2 , corresponding to N 229 in VPAC 1 , was essential for receptor activation (Nachtergael et al., M O L # 6 3 5 7 8 2 0
A, D or even K did not confer ligand-independent activation, the authors proposed that the replacement by an arginine provokes subtle conformational changes that do not simply remove some stabilizing interactions, as seen in family A GPCRs (Gaudin et al., 1998) . On the other hand, it has also been shown that E 394 located at the junction of TM7 and the Cterminus of VPAC 1 was important for G protein activation but not for coupling (Couvineau et al., 2003) .
In agreement with these data and on the basis of the present results, we propose that, in . These residues may therefore be involved in a binding and activation mechanism that is common to the whole GPCR-B family. However, additional experiments on other family members should be performed to support this view. (Ballesteros and Weinstein, 2005) . The conserved residues in TM helices of VPAC 1 receptor may serve as a "signature" for automated identification of family B GPCRs from the sequence (Bissantz et al., 2004) . Notice that virtually none of such residues coincide in both families. The average calculated degree of sequence identity of TM helices on the alignment is about 10%, which is at the lower boundary of the so-called "twilight zone" in comparative modelling (Baker and Sali, 2001 ).
Other alignment variants that where used for construction of the "final" (this one) are shown in Fig. S1 in Supplementary Material. This article has not been copyedited and formatted. The final version may differ from this version. (Solano et al., 2001 ) and b from (Nachtergael et al., 2006) .
